The aim is to compare the effectiveness of P-CABs versus PPIs in preventing upper gastrointestinal bleeding among users of anti-thrombotic medications.
Discussion of existing literature on P-CABs and PPIs for GI protection.
Analysis of treatment implications for patients on anti-thrombotic therapy.
P-CABs show a potentially greater efficacy in preventing upper GI bleeding compared to PPIs.
Evidence suggests a need for personalized treatment approaches in this patient population.